These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 549003)

  • 41. Aluminium intoxication in undialysed adults with chronic renal failure.
    Russo LS; Beale G; Sandroni S; Ballinger WE
    J Neurol Neurosurg Psychiatry; 1992 Aug; 55(8):697-700. PubMed ID: 1527541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Aluminum poisoning in renal dialysis patients: bone histology. Value of quantitative bone biopsy].
    Charhon SA; Chapuy MC; Traeger J; Meunier PJ
    Presse Med; 1984 Jun; 13(23):1431-4. PubMed ID: 6233588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scalp hair as an indicator of aluminium exposure: comparison to bone and plasma.
    Wilhelm M; Passlick J; Busch T; Szydlik M; Ohnesorge FK
    Hum Toxicol; 1989 Jan; 8(1):5-9. PubMed ID: 2785480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalacia.
    Fournier A; Fohrer P; Leflon P; Moriniere P; Tolani M; Lambrey G; Demontis R; Sebert JL; Van Devyver F; Debroe M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():371-6. PubMed ID: 3991525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.
    Mazzeo-Farina A; Cerulli N
    Clin Chim Acta; 1985 Apr; 147(3):247-54. PubMed ID: 3995774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?
    Pepper R; Campbell N; Yaqoob MM; Roberts NB; Fan SL
    BMC Nephrol; 2011 Oct; 12():55. PubMed ID: 21992770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure.
    Candy JM; McArthur FK; Oakley AE; Taylor GA; Chen CP; Mountfort SA; Thompson JE; Chalker PR; Bishop HE; Beyreuther K
    J Neurol Sci; 1992 Feb; 107(2):210-8. PubMed ID: 1564520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of aluminum in the development of osteomalacia in patients on chronic hemodialysis].
    Adamiec R; Uzar J
    Pol Arch Med Wewn; 1988 Jan; 79(1):3-12. PubMed ID: 3275167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accumulation of aluminium in patients with acute renal failure.
    Davenport A; Roberts NB
    Nephron; 1989; 52(3):253-8. PubMed ID: 2739864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Localisation of aluminium by histochemical and electron probe x-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy.
    Smith PS; McClure J
    J Clin Pathol; 1982 Nov; 35(11):1283-93. PubMed ID: 7142436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Silicon and aluminium interactions in haemodialysis patients.
    Parry R; Plowman D; Delves HT; Roberts NB; Birchall JD; Bellia JP; Davenport A; Ahmad R; Fahal I; Altmann P
    Nephrol Dial Transplant; 1998 Jul; 13(7):1759-62. PubMed ID: 9681724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.
    Ward MK; Feest TG; Ellis HA; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8069):841-5. PubMed ID: 76795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein binding of aluminium in normal subjects and in patients with chronic renal failure.
    Rahman H; Channon SM; Skillen AW; Ward MK; Kerr DN
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():360-5. PubMed ID: 3991523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.
    Fleming LW; Stewart Wk; Fell GS; Halls DJ
    Clin Nephrol; 1982 May; 17(5):222-7. PubMed ID: 7094439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum aluminium measurements in renal bone disease.
    Lancet; 1983 May; 1(8334):1168-9. PubMed ID: 6133187
    [No Abstract]   [Full Text] [Related]  

  • 56. [Aluminium in chronic renal replacement therapy patients undergoing haemodialysis in two renal units in Bogotá].
    Cárdenas O; Segura O; Puentes W; Sanabria M; Nava G; Torrenegra R
    Rev Salud Publica (Bogota); 2010 Aug; 12(4):669-81. PubMed ID: 21340131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary aluminium excretion following renal transplantation and the effect of pulse steroid therapy.
    Davenport A; Davison AM; Newton KE; Will EJ; Giles GR; Toothill C
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():25-32. PubMed ID: 2310153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aluminium in bone from patients with renal failure.
    Parsons V; Davies C; Goode C; Ogg C; Siddiqui J
    Br Med J; 1971 Oct; 4(5782):273-5. PubMed ID: 5123910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum aluminium measurement by DC plasma emission spectrometry.
    Roberts NB; Williams P
    Ann Clin Biochem; 1988 Mar; 25 ( Pt 2)():169-75. PubMed ID: 3382147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The clinical impact of aluminium overload in renal failure.
    Cannata-Andía JB; Fernández-Martín JL
    Nephrol Dial Transplant; 2002; 17 Suppl 2():9-12. PubMed ID: 11904351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.